메뉴 건너뛰기




Volumn 130, Issue 2, 2009, Pages 200-201

Acute viral hepatitis as a confounding factor in patients with antituberculosis treatment induced hepatotoxicity

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ISONIAZID; PHENYTOIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

EID: 70349548606     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (8)

References (6)
  • 1
    • 65949106572 scopus 로고    scopus 로고
    • Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity
    • Sarda P, Sharma SK, Mohan A, Makharia G, Jayaswal A, Pandey RM, et al. Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity. Indian J Med Res 2009; 129: 64-7.
    • (2009) Indian J Med Res , vol.129 , pp. 64-67
    • Sarda, P.1    Sharma, S.K.2    Mohan, A.3    Makharia, G.4    Jayaswal, A.5    Pandey, R.M.6
  • 3
    • 0030039365 scopus 로고    scopus 로고
    • Risk factors for hepatotoxicity from anti-tuberculosis drugs: A case control study
    • Pande JN, Singh SPN, Khilnani GC, Khilnani S, Tandon RK. Risk factors for hepatotoxicity from anti-tuberculosis drugs: a case control study. Thorax 1996; 51: 132-6.
    • (1996) Thorax , vol.51 , pp. 132-136
    • Pande, J.N.1    Singh, S.P.N.2    Khilnani, G.C.3    Khilnani, S.4    Tandon, R.K.5
  • 4
    • 0036796798 scopus 로고    scopus 로고
    • Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment
    • Sharma SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med 2002; 166: 916-9.
    • (2002) Am J Respir Crit Care Med , vol.166 , pp. 916-919
    • Sharma, S.K.1    Balamurugan, A.2    Saha, P.K.3    Pandey, R.M.4    Mehra, N.K.5
  • 5
    • 29144433189 scopus 로고    scopus 로고
    • Global prevalence of hepatitis A, B, and C
    • Global prevalence of hepatitis A, B, and C. WHO Wkly Epidemiol Rec 2002; 77: 6.
    • (2002) WHO Wkly Epidemiol Rec , vol.77 , pp. 6
  • 6
    • 0003514452 scopus 로고    scopus 로고
    • Department of Communicable Disease Surveillance and Response WHO/CDS/CSR/EDC/2001.12
    • Hepatitis E. World Health Organization. Department of Communicable Disease Surveillance and Response WHO/CDS/CSR/EDC/2001.12.
    • World Health Organization
    • Hepatitis, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.